Indian Market Pulse

Hero Title Overconfidence Bias with Subtitle About Indian Investors and Stock picking Skills Color block Infographic Below Showing Four States
Overconfidence Bias: Why Indian Investors Overestimate Their Stock-Picking Skills — And How This Silent Bias Is Destroying Your Portfolio Returns
April 3, 2026
Infographic Showing Fi and Dii Flows by Fiscal Year from Fy20 to Fy25 with Bars Values 28 26 22 18 14 and 11 fy25 Highlighted in Green
FII and DII Flows: How Institutional Money Moves the Indian Stock Market — Why Understanding These Flows Gives You an Unfair Advantage as a Value Investor
April 3, 2026
Infographic Titled Indian Market Pulse with a Horizontal Bar Chart of Fy20fy25 Values 28 26 22 18 14 11 fy25 Shown in Green

#image_title

VALUE INVESTING · BLOG

Indian Market Pulse

← ALL ARTICLES
Mbcover Indian Market Pulse Live Dashb - Manish Goel Portfolio Management Service

🇮🇳 Indian Market Pulse — Live Dashboard

Your Daily Snapshot of Markets, Macro & Value Investing Insights

Data as of: Monday, April 13, 2026 (Market closed April 14 — Dr. Ambedkar Jayanti)

🟡 Market Mood: CAUTIOUS

NIFTY down 0.86% — Stay invested in quality, don’t panic sell. Short-term dips create long-term wealth for disciplined investors.

NIFTY 50

23,842.65

▼ -207.95 (-0.86%)

SENSEX

76,847.57

▼ -702.68 (-0.91%)

Bank Nifty

55,605.05

▼ -307.70 (-0.55%)

USD / INR

₹93.20

Exchange Rate

Brent Crude

5-year trajectory
Figure 1. 5-year trajectory — Audited FY20-FY25 (Titan-illustrative)

$102.47

▲ Oil prices elevated

📊 Institutional Flow (April 13, 2026)

FII / FPI

-₹1,983 Cr

Net Sellers

DII

+₹2,432 Cr

Net Buyers

💡 Investor Insight: FII selling creates opportunities for patient value investors. DIIs continue to absorb selling pressure — a sign of domestic market confidence. Stay focused on fundamentals, not FII headlines.

Featured: Titan Biotech Ltd (BSE: 524717)

Today’s Close

₹410.00

▼ -21.55 (-4.99%)

Market Cap

~₹305 Cr

Small Cap Gem

📌 Short-term noise. Business fundamentals remain rock-solid. Titan Biotech’s 94% Q3 profit growth, near debt-free balance sheet, and 29% 10-year profit CAGR speak louder than any single day’s price action. Today’s dip is a temporary price movement — quality companies always reward patient investors.

ROCE

FY25 decomposition
Figure 2. FY25 decomposition — Where the ratio comes from

16.9%

Promoter

55.78%

10Y CAGR

29%

Q3 Growth

94%

⚠️ Why Value Investing Beats F&O — Every Single Time

✅ Value Investing

₹1 Lakh in Titan Biotech 5 years ago → ₹50+ Lakh today. That’s the power of compounding in quality businesses.

❌ F&O Trading

₹1 Lakh in F&O → 90% of traders lose everything (SEBI data). Don’t gamble — invest wisely.

🎓 Learn Value Investing — FREE Course by Manish Goel

Master the art of finding multibagger stocks. No F&O, no shortcuts — just quality investing.

▶ Watch Free Course on YouTube

🕐 Last Updated: April 14, 2026, 5:00 PM IST

(Data reflects April 13, 2026 closing — Market holiday on April 14)

Disclaimer: This dashboard is for educational purposes only. Past performance is not indicative of future results. Always do your own research before investing. The author may hold positions in stocks mentioned. This is NOT investment advice — consult a SEBI-registered advisor.

© 2026 manishgoelpms.com by Manish Goel | Built with ❤️ for value investors

MG Manish Goel Portfolio Management Service
SEBI Registered Research Analyst · Registration No. INH100004775 · Principal Officer: Manish Goel · 2209, Sector 63, Chandigarh — 160047, India
Investments are subject to market risks. Past performance is not indicative of future returns. Please read all documents carefully.
© 2026 Manish Goel Portfolio Management Service. All rights reserved. · Privacy · Disclaimer
author avatar
Manish Goel
Manish Goel is a Chartered Accountant, SEBI Registered Research Analyst, and founder of Manish Goel PMS. A full-time value investor since 2010, he has helped thousands of investors build long-term wealth through quality stock picking and disciplined fundamental analysis.
+91-7380122211